Personal information

Verified email domains

Statistics, Genomics, Epidemiology
Sweden, Germany, India

Activities

Employment (1)

Lund University: Lund, SE

2019-01-09 to 2021-08-31 | Postdoctoral researcher (Division of Clinical genetics)
Employment
Source: Self-asserted source
Subhayan Chattopadhyay

Education and qualifications (3)

Ruprecht Karls Universität Heidelberg: Heidelberg, Baden-Württemberg, DE

2016-09 to present | PhD (Department of Medicine)
Education
Source: Self-asserted source
Subhayan Chattopadhyay

Deutsches Krebsforschungszentrum: Heidelberg, Baden-Württemberg, DE

2016-09-01 to present | Dr. Sc. Hum. (Molecular Genetic Epidemiol;ogy)
Education
Source: Self-asserted source
Subhayan Chattopadhyay

University of Hyderabad: Hyderabad, Telangana, IN

2014-06 to 2016-05 | Master of Science (School of Mathematics and Statistics)
Education
Source: Self-asserted source
Subhayan Chattopadhyay

Funding (1)

Multiple myeloma

Contract
Bundesministerium für Bildung und Forschung (Heidelberg, DE)
Source: Self-asserted source
Subhayan Chattopadhyay

Works (23)

Cancer Predisposition Genes in Cancer-Free Families.

Cancers
2020-09-27 | Journal article
Source: Self-asserted source
Subhayan Chattopadhyay

Genome-wide study on uveal melanoma patients finds association to DNA repair gene TDP1.

Melanoma research
2020-04-01 | Journal article
Source: Self-asserted source
Subhayan Chattopadhyay

Association between tumor characteristics and second primary cancers with cutaneous melanoma survival: A nationwide cohort study.

Pigment cell & melanoma research
2020-02-19 | Journal article
Source: Self-asserted source
Subhayan Chattopadhyay

Second Primary Cancers in Melanoma Patients Critically Shorten Survival.

Clinical epidemiology
2020-01-23 | Journal article
Source: Self-asserted source
Subhayan Chattopadhyay

Eight novel loci implicate shared genetic etiology in multiple myeloma, AL amyloidosis, and monoclonal gammopathy of unknown significance.

Leukemia
2019-11-06 | Journal article
Source: Self-asserted source
Subhayan Chattopadhyay

Analysis of 153 115 patients with hematological malignancies refines the spectrum of familial risk.

Blood
2019-08-08 | Journal article
Source: Self-asserted source
Subhayan Chattopadhyay

Second Primary Cancers in Patients with Invasive and In Situ Squamous Cell Skin Carcinoma, Kaposi Sarcoma, and Merkel Cell Carcinoma: Role for Immune Mechanisms?

The Journal of investigative dermatology
2019-07-06 | Journal article
Source: Self-asserted source
Subhayan Chattopadhyay

Second primary cancers in non-Hodgkin lymphoma: Family history and survival.

International journal of cancer
2019-05-15 | Journal article
Source: Self-asserted source
Subhayan Chattopadhyay

Second cancers and causes of death in patients with testicular cancer in Sweden.

PloS one
2019-03-28 | Journal article
Source: Self-asserted source
Subhayan Chattopadhyay

Types of second primary cancers influence survival in chronic lymphocytic and hairy cell leukemia patients.

Blood cancer journal
2019-03-26 | Journal article
Source: Self-asserted source
Subhayan Chattopadhyay

Genome-wide interaction and pathway-based identification of key regulators in multiple myeloma.

Communications biology
2019-03-04 | Journal article
Source: Self-asserted source
Subhayan Chattopadhyay

Genome-wide association study of monoclonal gammopathy of unknown significance (MGUS): comparison with multiple myeloma.

Leukemia
2019-02-08 | Journal article
Source: Self-asserted source
Subhayan Chattopadhyay

Second primary cancers in patients with acute lymphoblastic, chronic lymphocytic and hairy cell leukaemia.

British journal of haematology
2019-01-31 | Journal article
Source: Self-asserted source
Subhayan Chattopadhyay

Familial risks of second primary cancers and mortality in ovarian cancer patients.

Clinical epidemiology
2018-10-11 | Journal article
Source: Self-asserted source
Subhayan Chattopadhyay

Familial Risks and Mortality in Second Primary Cancers in Melanoma.

JNCI cancer spectrum
2018-10-01 | Journal article
Source: Self-asserted source
Subhayan Chattopadhyay

Prostate cancer survivors: Risk and mortality in second primary cancers.

Cancer medicine
2018-10-01 | Journal article
Source: Self-asserted source
Subhayan Chattopadhyay

Second primary cancers in non-Hodgkin lymphoma: Bidirectional analyses suggesting role for immune dysfunction.

International journal of cancer
2018-09-21 | Journal article
Source: Self-asserted source
Subhayan Chattopadhyay

Impact of family history of cancer on risk and mortality of second cancers in patients with prostate cancer.

Prostate cancer and prostatic diseases
2018-09-05 | Journal article
Source: Self-asserted source
Subhayan Chattopadhyay

Multiple myeloma: family history and mortality in second primary cancers.

Blood cancer journal
2018-08-07 | Journal article
Source: Self-asserted source
Subhayan Chattopadhyay

Risk of second primary cancer following myeloid neoplasia and risk of myeloid neoplasia as second primary cancer: a nationwide, observational follow up study in Sweden.

The Lancet. Haematology
2018-08-01 | Journal article
Source: Self-asserted source
Subhayan Chattopadhyay

Familial risks of acute myeloid leukemia, myelodysplastic syndromes, and myeloproliferative neoplasms.

Blood
2018-07-10 | Journal article
Source: Self-asserted source
Subhayan Chattopadhyay

Enrichment of B cell receptor signaling and epidermal growth factor receptor pathways in monoclonal gammopathy of undetermined significance: a genome-wide genetic interaction study.

Molecular medicine (Cambridge, Mass.)
2018-06-11 | Journal article
Source: Self-asserted source
Subhayan Chattopadhyay

Identification and functional analysis of essential, conserved, housekeeping and duplicated genes.

FEBS letters
2016-05-17 | Journal article
Source: Self-asserted source
Subhayan Chattopadhyay

Peer review (7 reviews for 2 publications/grants)

Review activity for Cancer causes & control. (5)
Review activity for Nature ecology & evolution. (2)